In Episode 214 of Hidden Forces, Demetri Kofinas speaks with Scott Gottlieb. Dr. Gottlieb is a physician who served as the head of the FDA from 2017 to 2019. He currently serves on the boards of Pfizer and Illumina and is a regular contributor to CNBC where he has become one of the most recognizable faces in America. His recently published book, “Uncontrolled Spread,” examines how the coronavirus and its variants overwhelmed our national defenses and outlines the steps he thinks we need to take in order to better protect ourselves and our country from the next pandemic.

The first half of Demetri’s conversation with Scott was spent examining the systemic failures that Dr. Gottlieb thinks exacerbated the scope of the Covid-19 pandemic, as well as the economic costs associated with the various lockdowns and shutdowns that were imposed in the very early days of the outbreak. Gottlieb also goes into detail about the biological mechanics of the virus, how it spreads, and what we’ve learned about best practices for protecting ourselves and those around us. The conversation then shifts to a discussion about the various vaccines, their effectiveness, how they work, as well as the risk of taking them and how to evaluate those risks when making your own decision about whether or not to get vaccinated. Demetri asks Dr. Gottlieb about alternative treatment options like Ivermectin and whether or not he thinks the mainstream media is censoring information about these types of alternative treatments.

This week’s premium content is a forty-minute afterthoughts segment that Demetri recorded right after the end of his conversation with Scott, where he reflects on not only what was discussed during the first hour, but also, many of the things that the two didn’t get to talk about like the lab leak hypothesis, the arguments for and against mandated vaccinations, the future of sequencing and genomic epidemiology, new antiviral drugs, the risk of new BSL-4 Facilities, and so much more.

If you enjoy the free content we produce every week, we encourage you to take the leap and become a premium subscriber, if you haven’t already. There's no commitment. You can cancel at any time and the entire library of subscriber content going all the way back to Episode 1 becomes instantly available to you, including the overtimes, afterthoughts, transcripts, and rundowns, depending on your tier. The rundown to this week’s episode is a nearly 30-page compendium full of notes, questions, images, and other materials that Demetri put together to help guide you through this conversation.

You can access the second part of this episode, as well as the transcript and rundown to this week’s conversation through the Hidden Forces Patreon Page. All subscribers gain access to our premium feed, which can be easily added to your favorite podcast application.

If you enjoyed listening to today’s episode of Hidden Forces you can help support the show by doing the following:

Subscribe on Apple Podcasts | Spotify | Stitcher | SoundCloud | YouTube | CastBox | RSS Feed

Write us a review on Apple Podcasts

Subscribe to our mailing list through the Hidden Forces Website

Producer & Host: Demetri Kofinas

Editor & Engineer: Stylianos Nicolaou

Subscribe & Support the Podcast at https://patreon.com/hiddenforces

Join the conversation on Facebook, Instagram, and Twitter at @hiddenforcespod

Follow Demetri on Twitter at @Kofinas

Episode Recorded on 01/05/2021

Scott Gottlieb is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. Dr. Gottlieb’s work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety. He serves on the boards of Pfizer Inc. and Illumina, Inc., is a resident fellow at the American Enterprise Institute and a partner at the venture capital firm New Enterprise Associates. Under his leadership, the FDA advanced new frameworks for the modern and safe and effective oversight of gene therapies, cell based regenerative medicines, targeted drugs, and digital health devices. The FDA implemented new reforms to standardize drug reviews and make historic improvements of post market data collection and the use of real-world evidence. Dr. Gottlieb is widely published in leading medical journals and periodicals, including The Wall Street Journal, The New York Times, and The Washington Post. He has held editorial positions on the British Medical Journal and the Journal of the American Medical Association and is a regular contributor to CNBC. Dr. Gottlieb is also the author of “Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic”. Dr. Gottlieb was a practicing hospitalist and he is an elected member of the National Academy of Medicine. He lives in Westport, Connecticut with his wife and three daughters.